ãããžã§ã¯ããªãŒããŒã®äžç°ã§ãã
ããŠããéããè ã®å·¥è³ãå®ãããïŒãåå æœèšããã®ã瀌ã¡ãã»ãŒãžãä»åãæåŸãšãªããŸãããæåŸã¯ãNPOæ³äººã¿ãµããã³ãã³äŒããã®ã瀌ã®ã¡ãã»ãŒãžã§ãã
---------------------------
ãæ¯æŽããã ããçæ§ãž
ãã®åºŠã¯ããéããè ã®å·¥è³ãå®ãããïŒããããžã§ã¯ãã«ãæ¯æŽããã ããŸããŠèª ã«ããããšãããããŸããéãããæã€äººã ã®ä»äºãäœãåºãããšãåºæ¥ããå·¥è³ãã¿ããªã«æã£ãŠåãã§ããããäºãå¬ããããšã§ãããäœããäžçªããããã®ã¯æ¯ããŠãã ãã£ãçæ§ã®ãæ°æã¡ã§ãã
æ¬åœã«ãããããšãããããŸããã
ãã®ãããžã§ã¯ããæºåããŠããæäžãæ³äººãšããŠæœèšã®æºè¶³åºŠèª¿æ»ãç®çã«ããã¢ã³ã±ãŒããéãããæã€é幎éã«åãæ©äŒããããŸãããããã€ãã®èšåã®äžã«ãäœãããŠããæã楜ããã§ããïŒããšããåããçšæããŠããŸããã
çµæã¯ãªããš6å²ãã®é幎ãã¡ããä»äºãããŠããæã楜ããããšåçããã®ã§ãããã£ã±ãããã®ãããžã§ã¯ããè¡ãã®ã¯ééãã§ã¯ãªããšç¢ºä¿¡ããŸããã
ãŸã ãŸã ãã³ããã®åœ±é¿ã¯ç¶ããŠããŸãããããŸã§åœããåã ãšæã£ãŠããäºã«å¶éããããããã©ããããæããæããããŸããã§ããããèãããšéãããæã€äººã ã¯ãããªãã©ãããããã£ãšæãç¶ããŠããã®ã§ã¯ãªãããšæãã®ã§ãã
é段ãäžããè»ãé転ãããæ°ã«å ¥ã£ãå°åã§æ®ãããèªåãé£ã¹ãããã®ãé£ã¹ãã»ã»ã»ã»
ãããã¯ãç§ãã¡ã«ãšã£ãŠã¯ãåœããåãã®ããã«æããŸãããæ²ããããšã«éãããæã€åœŒãã«ã¯æ±ºããŠåœããåã§ã¯ãããŸãããããã©ããããå¿ç¡ãèšèãæãããããããè¿·æã åäŸãç¡ãçã§åé¡è§£æ±ºã«åãåã£ãŠãããªãå Žåãå€ã ãããŸããçµæçã«ããã©ããããæããŠããŠãããã®æ°æã¡ãæŒã殺ããŠçããŠããéããè ã®äººã ããããŠããããªç¶æ ã®éããè ã®äººã ããåœããåãã ãšæãçããŠãã人ã ããšããå³åŒãåºæ¥ãŠããŸã£ãŠããã®ãçŸç¶ã ãšæããŸãã
After COVID-19ã®äžçã¯ã©ããªé¢šã«ãªã£ãŠããã®ã§ãããããä»ãããé£ã«ãã誰ãã®ãå°ã£ãããããã©ãããããšããæ°æã¡ã«å¯ãæ·»ããããããªäžçã«ãªã£ãŠããããšãé¡ããŸãã
NPOæ³äººã¿ãµããã³ãã³äŒããããžã§ã¯ããªãŒããŒãäžç°
---------------------------